Acidic Exo-Polysaccharide Obtained from Bacillus sp. NRC5 Attenuates Testosterone-DMBA-Induced Prostate Cancer in Rats via Inhibition of 5 α-Reductase and Na+/K+ ATPase Activity Mechanisms

[1]  M. Mahmoud,et al.  Production, structural and biochemical characterization relevant to antitumor property of acidic exopolysaccharide produced from Bacillus sp. NRC5 , 2021, Archives of Microbiology.

[2]  E. Youness,et al.  Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer , 2020, Breast cancer : basic and clinical research.

[3]  H. G. van der Poel,et al.  Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. , 2020, European urology focus.

[4]  J. Tosoian,et al.  The continuing debate of 5-alpha reductase inhibitors and prostate cancer risk , 2018, Translational Cancer Research.

[5]  V. Chandramohan,et al.  Association between Low Serum Testosterone and Prostate Cancer Behaviour , 2018, International Journal of Contemporary Medical Research [IJCMR].

[6]  E. Youness,et al.  Protective and therapeutic effect of Vitex agnus-castus against prostate cancer in rat , 2018 .

[7]  Mohamed El awady,et al.  Production, characterization and biological activities of acidic exopolysaccharide from marine Bacillus amyloliquefaciens 3MS 2017. , 2017, Asian Pacific journal of tropical medicine.

[8]  Amal S. Ibrahim,et al.  Cancer: The Growing Monster in Egypt , 2016 .

[9]  A. Partin,et al.  Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk , 2015, Therapeutic advances in urology.

[10]  Ahmed Abulfotooh Eid,et al.  Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center , 2014, Central European journal of urology.

[11]  S. Yu,et al.  Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells , 2014, BMC Cancer.

[12]  Xuliang Jiang,et al.  Structural biology of glycoprotein hormones and their receptors: Insights to signaling , 2014, Molecular and Cellular Endocrinology.

[13]  J. Pinthus,et al.  Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics , 2013, Prostate Cancer and Prostatic Diseases.

[14]  K. V. Donkena,et al.  Oxidative Stress and DNA Methylation in Prostate Cancer , 2010, Obstetrics and gynecology international.

[15]  Zhong-wei Xu,et al.  Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. , 2010, Biological & pharmaceutical bulletin.

[16]  M. Gallucci,et al.  Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy , 2009, International journal of urology : official journal of the Japanese Urological Association.

[17]  J. Burnett,et al.  High-Density Lipoprotein (HDL) Cholesterol , 2009 .

[18]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[19]  G. Scheiner-Bobis,et al.  Ouabain activates signaling pathways associated with cell death in human neuroblastoma. , 2007, Biochimica et biophysica acta.

[20]  A. Bertorello,et al.  Na+, K+ -ATPase: an indispensable ion pumping-signaling mechanism across mammalian cell membranes. , 2006, Seminars in nephrology.

[21]  L. Drudge-Coates.  Prostate cancer and the principles of hormone therapy treatment , 2005 .

[22]  P. Sooriakumaran,et al.  The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review. , 2005, International journal of surgery.

[23]  J. Lewin,et al.  Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. , 2004, Cancer research.

[24]  G. Bubley,et al.  Association between prostate cancer and serum testosterone levels , 2002, The Prostate.

[25]  F. Fitzpatrick,et al.  Cyclooxygenase-2 and carcinogenesis. , 2000, Biochimica et biophysica acta.

[26]  S. Matsubara,et al.  Effects of soy milk and bifidobacterium fermented soy milk on lipid metabolism in aged ovariectomized rats. , 1998, Bioscience, biotechnology, and biochemistry.

[27]  M. Bosland.  Animal models for the study of prostate carcinogenesis , 1992, Journal of cellular biochemistry. Supplement.

[28]  I. Fridovich,et al.  Superoxide dismutases. , 1975, Annual review of biochemistry.

[29]  I. Carlberg,et al.  Glutathione reductase. , 1985, Methods in enzymology.

[30]  L. Prencipe,et al.  Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. , 1982, Clinical chemistry.

[31]  O. Griffith,et al.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. , 1980, Analytical biochemistry.

[32]  P. Tarli,et al.  Simplified enzymic/colorimetric serum urea nitrogen determination. , 1979, Clinical chemistry.

[33]  Van Pelt Lf.  Ketamine and xylazine for surgical anesthesia in rats. , 1977 .

[34]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[35]  J. Sadowski,et al.  [Renal function]. , 1973, Polskie Archiwum Medycyny Wewnetrznej.

[36]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[37]  W. Watson,et al.  Albumin standards and the measurement of serum albumin with bromcresol green. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[38]  N. Gochman,et al.  Automated determination of uric acid, with use of a uricase-peroxidase system. , 1971, Clinical chemistry.

[39]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[40]  S REITMAN,et al.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. , 1957, American journal of clinical pathology.

[41]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.